Paxlovid Explained:

I just finished my 5-day course of Paxlovid, the oral antiviral pill that I think there are a lot of questions about. I talk to top doctors to get answers about it, including cancer specialists and Dr. David Nguyen, an infectious diseases specialist at Univ. of California, San Francisco (UCSF), a top healthcare system.

Don't forget to drop a comment below on your own COVID-19-related drug experience (Paxlovid, molnupiravir or Lagevrio, Evusheld, etc.).

This video is to address some of those top questions, including:
00:00 - Intro
05:46 - Who should be on Paxlovid?
07:46 - Getting access to Paxlovid
09:37 - Dealing with such a new medication (and little public info!)
11:56 - Do former cancer patients qualify as "higher-risk" and "immunocompromised" for COVID-19

Join Our Community:
Website : https://www.thepatientstory.com/
Facebook: @ThePatientStory
Instagram: @ThePatientStory
Twitter: @patient_story

____________________________

#ThePatientStory #covid-19 #covidmedicine #Pfizer #Paxlovid #Cancerstories #Cancerpatients #cancersurvivors